MS drug put to the test: can it stop people from falling?
NCT ID NCT06629428
Summary
This study is testing if the drug ublituximab can improve walking, balance, and reduce the risk of falls in people with relapsing multiple sclerosis (MS). Twenty-five participants will receive the drug for 48 weeks. Researchers will measure their walking ability, disease status, and even test their balance by causing unexpected slips on a treadmill to see how well they recover.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atlanta Neuroscience Institute
RECRUITINGAtlanta, Georgia, 30327, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Georgia State University
NOT_YET_RECRUITINGAtlanta, Georgia, 30303, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.